Sleep Apnea at the American Thoracic Society Annual Meeting
In recent years, there has been a greater recognition of the cardiovascular and other health-related effects of breathing-related sleep disorders, particularly obstructive sleep apnea (OSA). At the same time, the disorder is being recognized and diagnosed more often. Today, about one in five adults has a high risk of OSA. The diagnosed prevalence is 2% to 20% depending on how the condition is defined.12,13
Thus, it is not surprising that more than 100 abstracts to be presented at ATS will deal with sleep-disordered breathing. A major focus is the link between metabolic disorders and OSA. One study, for instance, found that more than 25% of 255 OSA patients studied had impaired glucose tolerance, a major risk factor for diabetes and other metabolic disorders.14 Others found that the severity of OSA predicted diabetes risk, impaired pancreatic beta cell function, and insulin resistance, and was also associated with a significantly higher incidence of arterial hypertension.15, 16, 14Take-home message: Patients who have been diagnosed with OSA, or who are at risk for OSA, most likely have other cardiometabolic symptoms that should be addressed.
Conversely, clinicians may want to evaluate patients with cardiometabolic and OSA risk factors for OSA. That is particularly important given evidence that treating OSA can improve metabolic markers. In one meta-analysis being presented at ATS, researchers evaluated 9 studies with a total of 220 subjects and found a favorable effect of continuous positive airway pressure (CPAP) on insulin resistance, although they noted that the studies were mostly observational.17
However, a double-blind randomized, crossover clinical trial published in The New England Journal of Medicine ahead of the meeting, which will also be presented orally at ATS, found that CPAP treatment for 3 months significantly reduced blood systolic and diastolic blood pressure, total cholesterol, non HDL cholesterol, LDL cholesterol, triglycerides, and glycated hemoglobin, compared to sham treatment. It reversed the metabolic syndrome in 11 of the 86 treated patients (13%) compared to only 1 who had the sham treatment.18
Just because your patients are diagnosed with OSA doesn’t mean you have to turn them over to a sleep specialist for treatment. A study that will be presented at ATS found that after 6 months of management in a primary care setting, patients with symptomatic, moderate-to-severe OSA managed in a primary care setting had comparable outcomes (change in Epworth Sleepiness Scale, Functional Outcomes of Sleep questionnaire, and CPAP compliance) to a similar group receiving usual care in a sleep center.19 The primary care intervention that involved home-based auto-titrating of CPAP.
Clinicians should also be aware of “overlap syndrome,” in which patients have comorbid OSA and COPD. An analysis of 4,116 individuals with COPD ranging from mild to very severe found that 15% also had physician-diagnosed OSA. These patients were more likely to be males who had a history of heavy smoking. They were also more likely to have cardiovascular disease (CVD), diabetes, and hypertension, with a much higher risk of heart failure. The more severe their COPD, the more likely they were to have OSA.20 Take-home message: To reduce the risk of comorbid heart failure, identify OSA in COPD patients and COPD in OSA patients and treating both conditions simultaneously.
1. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648-54.
2. Toljamo T, et al. Value Of COPD Assessment Test (CAT) In Symptomatic Smokers Without COPD. T. Toljamo, Am J Respir Crit Care Med 185;2012:A1505
3. Miyazaki M, et al. Analysis Of Comorbid Factors Raising CAT Scores In COPD Patients With Mild Airflow Limitation. Am J Respir Crit Care Med;185;2012:A1507
4. Mackay AJ, et al. Utility Of The COPD Assessment Test (CAT) To Evaluate Severity Of COPD Exacerbations. Am J Respir Crit Care Med 185;2012:A1513
5. Gomes T, et al. Measuring The Real Impact To Improve Management Of Disease. Am J Respir Crit Care Med 185;2012:A1508
6. Lin K, Watkins B, Johnson T, Rodriguez JA, Barton MB. Screening for Chronic Obstructive Pulmonary Disease Using Spirometry: Summary of the Evidence for the U.S. Preventive Services Task Force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2008.
7. N. Raghavan, et al. Utility Of The COPD Assessment Test (CAT) In Predicting A Diagnosis Of COPD. Am J Respir Crit Care Med 185;2012:A1506
8. Mullerova H, et al. Disease Burden Of Dyspnea In A Primary Care COPD Population. Am J Respir Crit Care Med 185;2012:A1518
9. Wong CJ, et al. Fatigue in patients with COPD participating in a pulmonary rehabilitation program. Int J Chronic Obstruct Dis. 2010;5:319-326.
10. Kentson MU, et al. Situational, Physiological And Psychological Factors Associated With COPD-Related Fatigue And Functional Limitations Due To Fatigue. Am J Respir Crit Care Med 185;2012:A1519
11. Payne C, Wiffen PJ, Martin S. Interventions for fatigue and weight loss in adults with advanced progressive illness. Cochrane Database Syst Rev. 2012 Jan 18;1:CD008427.
12. Young T, Palta M, Dempsey J, et al. Burden of sleep apnea: rationale, design, and major findings of the Wisconsin Sleep Cohort study. WMJ. 2009;108(5):246
13. Epstein LJ, Kristo D, Strollo PJ, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5(3):263.
14. Sliwinksi P, et al. Relationship Between Arterial Hypertension And Impaired Glucose Tolerance (IGT) In Obstructive Sleep Apnoea (OSA) Patients. Am J Respir Crit Care Med. 185;2012:A2161
15. Gu C, et al. Impaired Glucose Tolerance And Pancreatic Beta Cell Function In Patients With Obstructive Sleep Apnea. Am J Respir Crit Care Med. 185;2012:A2165.
16. Zhao Q, et al. Correlation Analysis Of Obstructive Sleep Apnea And Insulin Resistance. Am J Respir Crit Care Med. 185;2012:A2163.
17. Iftikhar I. Meta-Analysis: Continuous Positive Airway Pressure Therapy Improves Insulin Resistance In Patients With Obstructive Sleep Apnea. Am J Respir Crit Care Med. 185;2012:A2162
18. Sharma SK, Agrawal S, Damodaran D, et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med. 2011 Dec 15;365(24):2277-86
19. Chai-Coetzer CL, et al. Randomised Controlled Trial To Evaluate A Simplified Model Of Care For Obstructive Sleep Apnea In Primary Care. Am J Respir Crit Care Med. 185;2012:A3853
20. Black-Shinn JL, et al. Overlap Syndrome Is Associated With Cardiovascular Disease. Am J Respir Crit Care Med. 185;2012:A2169
21. Tarini BA, et al. Systematic Review of the Relationship Between Early Introduction of Solid Foods to Infants and the Development of Allergic Disease. Arch Pediatr Adolesc Med. 2006;160:502-507
22. Zutavern A, et al. Timing of solid food introduction in relation to eczema, asthma, allergic rhinitis, and food and inhalant sensitization at the age of 6 years: results from the prospective birth cohort study LISA. Pediatrics. 2008 Jan;121(1):e44-52.
23. Concepcion E, et al. Exercise Induced Bronchospasm In Asthmatic And Non-Asthmatic Obese Children. Am J Respir Crit Care Med. 185;2012:A1767.
24. Jolly GP, et al. Evaluation Of Inhaler Usage Technique And Response To Educational Training In A Tertiary Health Care Centre. Am J Respir Crit Care Med. 185;2012:A3328
25. Lo T, et al. Modern Inhalers: to What Degree Are We Capable of Remembering How to Use Them? Am J Respir Crit Care Med. 185;2012:A3331